8:30 am Welcome Coffee & Registration

The Move from In-house to Clinical Outsourcing

9:30 am Chair’s Opening Address

  • Joe Carvalho Director, Global Category Manager Scientific Services , Novartis

9:40 am The Current R&D Procurement Landscape and the Comeback of Supplier Relationship Management (SRM) in the R&D Program

  • Joe Carvalho Director, Global Category Manager Scientific Services , Novartis


• What are the current trends within R&D procurement and sourcing including increasing dependence upon data
• What is SRM’s place within Sourcing and Procurement
• What value can be added from a dedicated SRM team
• Approaches to improving both existing and new partnerships for long-term gain

10:25 am Vendor Management vs. Category Management – Orchard Therapeutics’ Journey to Support an Increasingly Complex and Global Business

  • Kris Ward Director, Procurement, Orchard Therapeutics


• Cost vs. benefits of each approach
• Gauging current/future organizational maturity, complexity and business needs to develop your procurement roadmap
• Influencing total cost of ownership to engrain procurement as a trusted business partner

10:55 am Speed Networking & Morning Coffee

11:55 am Discussion: Vendor Oversight and Risk Management Approaches Across the Pharma Industry


• Large, mid-sized and small pharma contrast how many internal resources are dedicated to vendor oversight activities? In what function do these resources reside?
• How are sponsors interpreting the guidelines in different ways, to avoid negative inspection?
• Having transitioned from large pharma to small biotech Rinaldo Doorman from Cerevel shares the difference in vendor oversight approaches

12:30 pm A fit-for-purpose R&D third party technical assessment – GSK Vaccines’ simplification of R&D partner’s compliance evaluation.


In a context of R&D Acceleration, how to streamline capability assessment in the due diligence process
Using a decision tree with few questions, how to save time and resources by performing only assessments that matter.
Aligning Procurement and Quality processes to define best time for vendor technical assessment
Vendor (on-paper) assessment vs. Vendor (on-site) auditing (Pro’s & Con’s)                                             

• The importance of cultural considerations when assessing R&D partners

1:00 pm Networking Lunch

2:00 pm Case Study on Supplier Spend Analytics for Clinical Trials


• Data sources and software application
• Supplier spend history for analytics and contract negotiation
• Supplier budget monitoring and metrics
• Supplier spend forecasting to predict future challenges

2:30 pm Case Study: Automating and Harmonizing RFP Processes for a Phase 3 Neurodegenerative Rare Disease Clinical Trial Using Clinical MaestroTM


• End the pitfalls of Excel-based budgeting and simulate clinical study budgets and operational scenarios in a few hours
• See how bid and cost driver standardization increases bidding transparency and drives down costs
• Leverage information provided in bid negotiations to help Sponsors better understand exactly what they are paying for: rates, effort and services
• Examine how the sourcing for a phase 3 study was completed in 101 fewer hours, or 84% faster than traditional sourcing tools, using Clinical Maestro

3:00 pm Your Voice. Participate in 1 of 3 discussions, the top 3 points from each table will be shared


A: Will collaboration for market insight on supplier cost help or hinder competition?

B: Onshore vs offshore:What delivers the biggest total cost savings?

C: What are you top 3 negotiation tactics for minimizing spend?

3:45 pm Afternoon Tea & Networking Break

4:45 pm Contracting – Who Drives the Content

  • Rose Prisco Associate Director Clinical Procurement, Pacira Pharmaceuticals


• Dissecting the best governance and processes between business, legal, procurement and compliance for airtight contracts. At what instances is a review of a standard contract needed?
• Importance of clear communication within your project team
• Procurements role in implementing training for budgeting and contracting within clinical trials

5:15 pm Innovative Sourcing Approaches from the Bill and Melinda Gates Medical Research Institution

  • Karan Paruvangada Strategic Sourcing Leader, Bill and Melinda Gates Medical Research Institution

5:45 pm Chair’s Closing Remarks

  • Joe Carvalho Director, Global Category Manager Scientific Services , Novartis

6:00 pm Close of Day 1